Literature DB >> 34016283

Candidemia and Invasive Candidiasis.

Todd P McCarty1, Cameron M White2, Peter G Pappas2.   

Abstract

Invasive candidiasis (IC) is a collective term that refers to a group of infectious syndromes caused by a variety of species of Candida, 6 of which cause most cases globally. Candidemia is probably the most commonly recognized syndrome associated with IC; however, Candida can cause invasive infection of any organ, especially visceral organs, vasculature, bones and joints, the eyes and central nervous system. Targeted prevention and empirical therapy are important interventions for patients at high risk for IC, and the current approach should be based on a combination of clinical risk factors and non-culture-based diagnostics, when available. Published by Elsevier Inc.

Entities:  

Keywords:  Antifungals; Bloodstream infection; Candida; Fungal infection; Invasive candidiasis

Mesh:

Substances:

Year:  2021        PMID: 34016283     DOI: 10.1016/j.idc.2021.03.007

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  11 in total

1.  Machine Learning in Infectious Disease for Risk Factor Identification and Hypothesis Generation: Proof of Concept Using Invasive Candidiasis.

Authors:  Lisa M Mayer; Jeffrey R Strich; Sameer S Kadri; Michail S Lionakis; Nicholas G Evans; D Rebecca Prevots; Emily E Ricotta
Journal:  Open Forum Infect Dis       Date:  2022-08-03       Impact factor: 4.423

2.  In vitro and in vivo anti-Candida activity of citral in combination with fluconazole.

Authors:  Katherine Miranda-Cadena; Cristina Marcos-Arias; Aitzol Perez-Rodriguez; Iván Cabello-Beitia; Estibaliz Mateo; Elena Sevillano; Lucila Madariaga; Guillermo Quindós; Elena Eraso
Journal:  J Oral Microbiol       Date:  2022-03-02       Impact factor: 5.474

Review 3.  Fungal Colonization and Infections-Interactions with Other Human Diseases.

Authors:  Shanmuga S Mahalingam; Sangeetha Jayaraman; Pushpa Pandiyan
Journal:  Pathogens       Date:  2022-02-06

4.  A Brazilian Inter-Hospital Candidemia Outbreak Caused by Fluconazole-Resistant Candida parapsilosis in the COVID-19 Era.

Authors:  Danilo Y Thomaz; Gilda M B Del Negro; Leidiane B Ribeiro; Mirian da Silva; Gabrielle O M H Carvalho; Carlos H Camargo; João N de Almeida; Adriana L Motta; Rinaldo F Siciliano; Odeli N E Sejas; Flávia Rossi; Edson Abdala; Tânia M V Strabelli; Gil Benard
Journal:  J Fungi (Basel)       Date:  2022-01-20

5.  Incidence of candidemia and prevalence of azole-resistant candidemia at a tertiary South African hospital - A retrospective laboratory analysis 2016-2020.

Authors:  Vindana Chibabhai
Journal:  S Afr J Infect Dis       Date:  2022-02-15

Review 6.  The Role of the Oral Immune System in Oropharyngeal Candidiasis-Facilitated Invasion and Dissemination of Staphylococcus aureus.

Authors:  Raymond Pasman; Bastiaan P Krom; Sebastian A J Zaat; Stanley Brul
Journal:  Front Oral Health       Date:  2022-04-07

7.  Magnolol as a potent antifungal agent inhibits Candida albicans virulence factors via the PKC and Cek1 MAPK signaling pathways.

Authors:  Yufei Xie; Hong Hua; Peiru Zhou
Journal:  Front Cell Infect Microbiol       Date:  2022-07-22       Impact factor: 6.073

Review 8.  Diagnosis and Treatment of Invasive Candidiasis.

Authors:  Natalia Barantsevich; Elena Barantsevich
Journal:  Antibiotics (Basel)       Date:  2022-05-26

9.  Pan-Echinocandin Resistant C. parapsilosis Harboring an F652S Fks1 Alteration in a Patient with Prolonged Echinocandin Therapy.

Authors:  Maria Siopi; Antonios Papadopoulos; Anastasia Spiliopoulou; Fotini Paliogianni; Nissrine Abou-Chakra; Maiken Cavling Arendrup; Christina Damoulari; Georgios Tsioulos; Efthymia Giannitsioti; Frantzeska Frantzeskaki; Iraklis Tsangaris; Spyros Pournaras; Joseph Meletiadis
Journal:  J Fungi (Basel)       Date:  2022-09-01

10.  Appropriate empirical antifungal therapy is associated with a reduced mortality rate in intensive care unit patients with invasive fungal infection: A real-world retrospective study based on the MIMIC-IV database.

Authors:  Man-Ka Zhang; Zhi-Guo Rao; Tao Ma; Ming Tang; Tian-Qi Xu; Xiao-Xu He; Zhou-Ping Li; Yin Liu; Qing-Jie Xu; Ke-Yu Yang; Yi-Fan Gong; Jing Xue; Mei-Qing Wu; Xiao-Yan Xue
Journal:  Front Med (Lausanne)       Date:  2022-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.